PremiumCompany AnnouncementsAnebulo Pharmaceuticals Advances Cannabis Toxicity Solutions ANEB Upcoming Earnings Report: What to Expect? Anebulo Pharmaceuticals Updates Corporate Presentation PremiumThe FlyAnebulo Pharmaceuticals price target lowered to $4 from $6 at Ladenburg New Debt & Financing Risk for Anebulo Pharmaceuticals, Inc. – What’s the Latest? ANEB Upcoming Earnings Report: What to Expect? PremiumThe FlyMaxim starts Anebulo at Buy on acute cannabis intoxication opportunity Anebulo Pharmaceuticals initiated with a Buy at Maxim Anebulo Pharmaceuticals reports Q4 EPS (10c), consensus (11c) 
